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Abstract
Background: Mobility limitations in older adults are associated with poor clinical outcomes including higher
mortality and disability rates. A decline in mobility (including physical function and life-space) is detectable and
should be discovered as early as possible, as it can still be stabilized or even reversed in early stages by targeted
interventions. General practitioners (GPs) would be in the ideal position to monitor the mobility of their older
patients. However, easy-to-use and valid instruments for GPs to conduct mobility assessment in the real-life practice
setting are missing. Modern technologies such as the global positioning system (GPS) and inertial measurement
units (IMUs) - nowadays embedded in every smartphone - could facilitate monitoring of different aspects of
mobility in the GP's practice.
Methods: This project’s aim is to provide GPs with a novel smartphone application that allows them to quantify
their older patients’ mobility. The project consists of three parts: development of the GPS- and IMU-based
application, evaluation of its validity and reliability (Study 1), and evaluation of its applicability and acceptance
(Study 2).
In Study 1, participants (target N = 72, aged 65+, ≥2 chronic diseases) will perform a battery of walking tests
(varying distances; varying levels of standardization). Besides videotaping and timing (gold standard), a high-end
GPS device, a medium-accuracy GPS/IMU logger and three different smartphone models will be used to determine
mobility parameters such as gait speed. Furthermore, participants will wear the medium-accuracy GPS/IMU logger
and a smartphone for a week to determine their life-space mobility. Participants will be re-assessed after 1 week. In
Study 2, participants (target N = 60, aged 65+, ≥2 chronic diseases) will be instructed on how to use the application
by themselves. Participants will perform mobility assessments independently at their own homes. Aggregated test
results will also be presented to GPs. Acceptance of the application will be assessed among patients and GPs. The
application will then be finalized and publicly released.
Discussion: If successful, the MOBITEC-GP application will offer health care providers the opportunity to follow their
patients’ mobility over time and to recognize impending needs (e.g. for targeted exercise) within pre-clinical stages
of decline.
Keywords: Aging, General practice, Multimorbidity, Walking speed, Mobility limitation, Smartphone, Geographic
information systems, Inertial sensors, Health promotion, Spatial behavior
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Background
Multimorbidity and health care for older adults
Demographic transformation and increasing life expect-
ancy in industrialized countries comes along with a grow-
ing number of older adults suffering from chronic health
conditions, such as osteoarthritis, coronary heart disease,
diabetes mellitus, or dementia [1]. The proportion of pa-
tients with “multimorbidity”, usually defined as the co-
occurrence of at least two chronic conditions [2], grows
accordingly. Figures on the prevalence of multimorbidity
among over 65-year-olds vary between 40 and 85% [2–5].
Multimorbidity is strongly associated with poor clinical
outcomes, including reduced quality of life [6], increased
risk of inappropriate medication with major side-effects
[5, 7] as well as high mortality and disability rates [8, 9].
The burden of disease is substantial for the affected
patients and their relatives, and also for the healthcare sys-
tem [10–12].
The simple definition of multimorbidity hardly accounts
for the complex relationships between concurrent chronic
diseases and the difficulties in managing multimorbid pa-
tients. It has been recognized that these patients’ needs
are insufficiently served by traditional ways of health care
provision [12–14]. One reason is the disease-oriented ra-
ther than integrated approach towards managing patients
with multimorbidity [15, 16]. Disease-specific guidelines
are often contradictory and impractical when applied to
multimorbid patients. Disease-oriented management often
results in polypharmacy and knowledge of potential side
effects, hazards and harm of interventions is insufficient
[15]. This lack of knowledge is even more striking, as it is
not clear whether traditional improvements in outcomes,
for example mortality, are attainable and desirable in pa-
tients with multimorbidity [16]. Patient and relative pref-
erences are frequently unmet, as are patient-oriented
outcomes such as improving physical functioning and
maintaining independence [17, 18]. There is even evidence
that the association between multimorbidity and mortality
is lost when adjusted for functional impairment [19].
Hence, there is increasing awareness of the importance of
physical functioning as a basic integrator of older adults’
health and as a major health outcome; optimizing func-
tional status has been recognized as a central goal for all
persons with chronic illness [20].
Mobility
“Mobility” is a central element of physical functioning [21,
22]. It has been defined comprehensively as “the ability to
move oneself (either independently or by using assistive de-
vices or transportation) within environments that expand
from one’s home to the neighbourhood and to regions be-
yond” ([23], p. 444). Hence, measures that have been used
to characterize a person’s mobility include tests of “physical
function” [24], and assessments of “life space” [25].
Lower extremity physical function can be measured by
simple tests such as stop-watch measured gait speed,
balance measures such as maintaining the tandem stand
for 10 s, or simple assessments of muscle power such as
timing of 5 sit-to-stand cycles [24, 26]. In relation to a
person’s mobility, gait speed is one of the most central
functional parameters. In prospective studies, poor phys-
ical function as well as reduced gait speed alone have
been shown to be highly predictive of falls [27, 28], de-
pendency in basic activities of daily living [29–31],
healthcare utilization [32–34], and mortality [35, 36]. Re-
duced physical function has been shown to foster social
isolation [37], anxiety and depression [38], and to be as-
sociated with an overall reduced quality of life [39].
Based on the existing evidence from large-scale pro-
spective studies, clinical cut-offs for functional measures,
indicating an increased risk for falls or an increased risk
for mobility disability, have been established [40–42], so
that these measures have found their way into routine
geriatric inpatient care and rehabilitation settings.
Life-space, the “spatial extent in which a person moves
within a specified period” ([43], p. 155), encompasses “the
interaction between intrinsic capabilities of the person
and the demands of the extrinsic environment” ([43], p.
155). It has been shown that restricted life-space is pre-
dictive of disability in activities of daily life (ADL) [44],
nursing home admission [45] and mortality [46]. Until
now, epidemiological studies mostly relied on question-
naires to measure life-space. However, the geospatial in-
formation gained from questionnaires is rather crude. As
an example, the University of Alabama at Birmingham
(UAB) Study of Aging Life-Space Assessment (LSA) as-
sesses the extent of a person’s movement (within the past
4 weeks) categorized into 5 spatial levels, ranging from the
participant’s bedroom to places outside the participants’
home town [25]. While the independent predictive value
of life-space on different health-related outcomes has been
shown repeatedly [45–48], recommendations on clinical
cut-offs are currently sparse (e.g .[ 49]) and measures of
life-space have not yet found their way into clinical
practice.
The necessity to assess mobility
Measures of functional status have been suggested to in-
form health care payment systems [50] and they are central
components of decision trees advocated by current fall pre-
vention guidelines [27, 41]. In early stages of decline, phys-
ical function can be stabilized or even reversed by targeted
intervention such as exercise programmes [51]. Life-space,
and thereby participation in social life, can be maintained
by adapting the environment to the patients’ needs (e.g. by
providing assistive devices, adapting patients’ homes or pro-
viding social support). Similar to chronic illness, physical
functioning is dynamic in nature [52]; mobility should
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therefore be routinely monitored to account for the dy-
namic interactions between physiological systems and the
environments of daily life over time. It has even been sug-
gested that functional status should be considered the
“sixth vital sign” in addition to the conventional vital signs
(body temperature, pulse etc.) [20, 53, 54].
The general practitioner’s practice – an opportunity for
targeting older adults’ mobility
As mentioned, physical function tests have found their
way into routine geriatric inpatient care and rehabilitation
settings, but general practitioners (GPs) do not routinely
assess physical function as part of their older patients’
management [55, 56]. This deficiency in administering as-
sessments might occur for a number of reasons: physical
function assessments (e.g. the measurement of 4m gait
speed) require standardized equipment, space and train-
ing; they are time- and therefore cost-intensive. There is a
lack of reimbursement and particularly in patients with
multiple chronic conditions, GPs have to weigh the
realization of functional assessments against other pre-
ventive and therapeutic services [57, 58]. These consider-
ations are in contrast to the ideal position that GPs would
have to monitor their older patients’ mobility. GPs are
among the few persons who have regular access to
community-dwelling and mobility-limited older adults
[59, 60]; they often have established long-lasting, ongoing
and trusting relationships with their older patients [61].
GPs are also able to appraise the results of a mobility as-
sessment against the background of their patients’ overall
health status and medical history.
New opportunities offered by modern technologies –
observing mobility in the “real-life” setting
Modern technologies such as Global Navigation Satel-
lite Systems (GNSS) – including various satellite
systems such as GPS, GLONASS, Galileo and Beidou
– and inertial measurement units (IMUs) – including
accelerometer, gyroscope and magnetometer – offer
the chance to implement measures of mobility (phys-
ical function and life-space) into routine primary
health care and to follow-up on older patients’ mobil-
ity over time. In contrast to traditional assessment
tools, these technologies allow for observation of
older adults function in real-life settings and in inter-
action with their environment [62, 63]. It has been
criticized in the past that laboratory-based functional
assessments only have limited value in predicting
older adults’ real-life mobility behaviour [64]. GNSS
technology and IMUs are nowadays embedded in
every modern smartphone, a device that has become
popular and shows much promise in improving the
health care of older adults. High availability,
objectivity and low additional costs might facilitate
widespread future use.
While high-end, handheld GPS devices can achieve
decimetre accuracy, typical consumer GPS devices or
smartphones will achieve best-case accuracies of 2–3m
under normal conditions [65]. Latest smartphone models
are also meant to achieve decimeter-level positioning ac-
curacy in post-processing mode, due to the ability to use
dual frequency GPS/GALILEO [66]. That is, consumer-
level products are starting to reach a positioning
accuracy level where accurate and robust movement
parameter derivation (e.g. distance, speed, acceleration
etc.) is becoming feasible, particularly for distances that
exceed the GPS error by at least one order of magnitude,
that is, several dozens to some hundred meters. So far,
however, the use of GPS-derived movement parameters
to quantify physical performance has mainly been lim-
ited to team sports [67, 68]. In the health sciences, most
applications have been confined to using GPS fixes to
estimate individuals’ life-spaces [69], often linking these
to active transport and body weight [70]. There are few
reports on applications of GPS-derived movement pa-
rameters in patient populations. A limited number of
studies have shown the reliability and applicability of
GPS-derived measures in a sample of patients with per-
ipheral arterial disease [71, 72].
Locomotion speed can already be accurately extracted
from IMU readings over shorter distances [73, 74]. Since
GPS and IMUs are standard components of contemporary
smartphones, there is potential for smartphone-based
measurements to replace or complement traditional –
usually stopwatch timed – walking tests over short dis-
tances (e.g. 10m). In contrast to GPS devices, IMUs do
not require satellites visibility, i.e. they can be used both
indoors and outdoors. On the other hand, GPS is the opti-
mal method to determine locations over longer periods of
time, and therefore the optimal method to assess life-
space mobility.
Steps to be taken
Though the sources quoted above have demonstrated
the potential of GPS- and IMU-derived measures, they
still have to be adapted to the new context and tested
for their reliability, validity, applicability and acceptance
before they can be routinely used by GPs to monitor
their patients’ mobility (physical function and life-space).
There is also a need to evaluate how GPS- and IMU-
derived mobility measures relate to traditional physical
function tests.
Methods and design
Aims and objectives
The overall goal of the MOBITEC-GP project is to pro-
vide GPs with the possibility to assess their older
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patients’ mobility using a collection of different mobility
parameters (related to physical function and life space).
The aims of the project are:
1. To develop an easy-to-use GPS- and IMU-based
smartphone application that allows GPs to quantify
and appraise their older patients’ mobility
(“Development”);
2. To evaluate the application’s validity and reliability
(“Study 1”);
3. To evaluate the new tools’ applicability and
acceptance among GPs and patients (“Study 2″).
An iterative development and evaluation process is re-
quired to fulfil all aims; it is illustrated in Fig. 1. The de-
velopment phases include requirement analyses among
GPs, patients and experts. While the first development
phase focuses on the app’s measurement properties, the
second development phase focusses on user interface de-
sign. The app will be specifically designed to create a
patient-GP partnership, i.e. the patient collects data of
daily functioning and the GP interprets and explains the
data to the patient, and plans the necessary measures
(such as referral to a comprehensive fall risk assessment
or to an exercise programme, home adaptations or
provision with adaptive devices) together with the
patient.
Specific objectives of Study 1 are:
1) To assess the test-retest reliability of GPS/IMU-de-
rived physical function measures (smartphone,
medium-accuracy GPS/IMU device, high-end GPS
device; see section ‘Measurements in Study 1’
below) obtained during standardized short-distance
mobility tasks (10 m and 50 m walks; “short distance
controlled condition”) and their validity against
“gold standard” (timing, video-recording).
2) To assess the test-retest reliability of GPS/IMU-de-
rived physical function measures (smartphone,
medium-accuracy GPS/IMU device, high-end GPS
device) obtained during a standardized long-
distance mobility task (400 m walk on a given track;
“long-distance controlled condition”) and their val-
idity against “gold standard” (timing, video-
recording).
3) To assess the test-retest reliability of GPS/IMU-de-
rived physical function measures (smartphone,
medium-accuracy GPS/IMU device, high-end GPS
device) obtained during a semi-standardized mobil-
ity task (30-min stroll in the park; “semi-controlled
Fig. 1 Iterative process of development and evaluation of the new smartphone application
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condition”) and their concurrent validity (against
traditional physical function tests).
4) To assess the test-retest reliability of GPS/IMU-de-
rived life-space measures (smartphone, medium-
accuracy GPS/IMU-device) during a one-week
measurement period around participants’ homes
(uncontrolled “real-life” condition) and their con-
current validity (against traditional physical function
tests).
5) To assess whether measurement properties
(validity, reliability) vary by key participant
characteristics (including demographic
characteristics, anthropometrics, and physical
function measures).
6) To assess whether measurement results (physical
function and life-space) vary by key participant
characteristics (including demographic characteris-
tics, physical activity level, gait efficacy, fall status,
and morbidity) to generate hypotheses for subse-
quent large-scale epidemiological studies.
7) To assess the inter-instrument agreement between
a high-end GPS device, a medium-accuracy GPS/
IMU device and three different smartphone models,
including agreement between the different smart-
phone models and agreement between smartphone
wearing locations.
8) To define cut-offs for indicators of different mobil-
ity levels against established clinical cut-offs based
on traditional physical function measures (from
existing epidemiological studies and current fall-
prevention guidelines).
Specific objectives of Study 2 are:
9) To assess the clinical applicability of unsupervised
GPS/IMU measurements with the smartphone
(fitted with the new application) in the real-life gen-
eral practice setting.
10) To assess usability and acceptance by GPs and
patients.
11) To assess participant characteristics that are
associated with the proportion of clinically usable
unsupervised GPS/IMU measurements.
Design
Study 1 and Study 2 will both be observational. Study 1
will be a validity and reliability study. At baseline (T0), a
battery of tests (visit at study center) as well as a 1-week
measurement around participants’ homes will be per-
formed. Cross-sectional analyses of baseline values will
be used to evaluate validity of the GPS and IMU-based
measurements as well as the inter-instrument agreement
between devices of different accuracy levels as well as
between different smartphone models. Participants will
be assessed again 1 week after the initial assessment (T1)
to evaluate test-retest-reliability of the GPS/IMU mea-
surements. T1 includes a visit at the study center and a
1-week measurement around participants’ homes.
Study 2 will be an applicability study: Patients
equipped with a smartphone (fitted with the new appli-
cation) will independently perform mobility measure-
ments around their homes for 1 week. The proportion of
technically satisfactory GPS/IMU recordings will be de-
termined. Reasons for unsuccessful recordings will be
assessed and analysed. Usability and acceptance by GPs
and patients will be evaluated.
Inclusion criteria
Both studies target community-dwelling older patients from
general practice with multiple chronic conditions, aged 65
or above. The target number of participants for Study 1 is
72, the target number of participants for Study 2 is 60. Par-
ticipants have to be diagnosed (self-report) with at least two
of the following chronic diseases (according to the “Self-Ad-
ministered Comorbidity Questionnaire” (SCQ) [75, 76]):
heart disease, high blood pressure, lung disease, diabetes,
ulcer or stomach disease, kidney disease, anemia or other
blood disease, cancer, depression, osteoarthritis, degenerative
arthritis, back pain and/or rheumatoid arthritis. Participants
have to be able to perform a 30-min outdoor walk at their
own pace, with or without breaks, with or without walking
aid, but without the help of another person (self-report).
Persons who are incapable of judgment and persons who
are unable to follow procedures or have insufficient know-
ledge of the German language will be excluded. Participants
will have to provide written informed consent.
Recruitment
The recruitment strategy will be twofold. On one hand,
participants will be recruited through GP practices. Pa-
tients who attend their GP within a given timeframe, are
capable of judgement and aged 65 or above will be asked
by the GP for their general interest in participating in a
study on “mobility”. If they agree they will be informed
about the study and assessed for eligibility by a research
team member. All eligible patients will be invited to par-
ticipate. On the other hand, participants will be recruited
through presentations about the project in local senior
citizen gatherings, individual invitations to persons who
expressed interest in participating in studies from our
institute, as well as handing out information brochures
about the study and individually approaching older
adults in settings such as pharmacies, churches, and se-
nior sports groups.
GP practices will be recruited from a network of prac-
tices associated with the Center of Primary Health Care,
University of Basel.
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Ethical considerations and ethical approval
The performed measurements will only include everyday
tasks (such as walking at preferred, habitual pace or ris-
ing from a chair), so that they do not involve an in-
creased cardiovascular or musculoskeletal risk compared
to everyday activity. During the walking tests, partici-
pants will be allowed to take a break at any time.
The new smartphone application will be designed in a
way that GPs are only provided with summary measures
of physical function and life-space mobility. GPs will not
have an insight into the raw movement data or locations
that older adults have visited.
The research is carried out in compliance with the
Helsinki Declaration. Data generation, transmission,
storage and analysis of health related personal data will
follow the current Swiss legal requirements for data pro-
tection. The project was approved by the Ethics Com-
mittee of Northwestern and Central Switzerland (EKNZ)
(Reg.-No. 2018–02257).
Measurements in study 1
GPS and IMU-based measures
GPS and IMU-based measurements will take place at
two points in time (T0 and T1) at the study center. Four
different mobility tasks including GPS and IMU-based
measurements will be performed. Tasks a) to c) will take
place at the study center; Task d) will take place in the
week immediately after each visit around participants’
homes. The devices used in Study 1 will include a high-
end GPS device (Trimble GeoExplorer 5 T, Trimble Inc.,
Sunnyvale, CA, USA); a medium accuracy GPS/IMU de-
vice (uTrail, CDD Ltd., Athens, Greece) and three differ-
ent models of contemporary dual-antenna smartphones
(Samsung Galaxy S8, Xiaomi Mi 8, Apple iPhone SE).
Task a): two supervised walks of 10 m and 50 m
length, at self-selected, habitual pace on an outdoors
athletics track (short-distance controlled condition).
These tasks will be videotaped (Garmin VIRB XE, Gar-
min Ltd., Olathe, KS, USA) and timed (light barrier sys-
tem; BROWER Timing Systems, Draper, UT, USA).
Participants will be equipped with the high-end GPS de-
vice, the medium accuracy GPS/IMU device and the three
smartphones. The three different smartphone models will
be worn at three different locations (waist belt, sling bag,
and neck pouch). This will be used to assess the influence
of wearing location and model on the results.
Task b): a supervised 400 m walk at self-selected, ha-
bitual pace on an outdoors athletics track (long-distance
controlled condition). This task will also be videotaped
and timed. Again, participants will be equipped with the
high-end GPS device, the medium-accuracy GPS/IMU
device and three smartphones.
Task c): an unsupervised 30-min stroll in a park at
self-selected, habitual pace without a given track (semi-
controlled condition). Participants will be equipped with
the high-end GPS device, the medium-accuracy GPS/
IMU device and three smartphones.
Task d): a one-week measurement period around par-
ticipants’ homes without any specified tasks (uncon-
trolled “real-life” condition). Participants will be
equipped with an uTrail device, a smartphone (random
choice of 1 of the 3 models) and a wrist-worn activity
tracker (see section ‘Traditional physical function tests
and physical activity’ below).
During all tasks, participants will be allowed to stop
and rest any time. There will be no recommendation
about minimum or maximum duration of stops. Wea-
ther conditions (temperature and cloud cover) will be
documented at T0 and T1; these parameters will be con-
sidered for sensitivity analyses as they might affect
reliability.
Data processing will include:
Tasks a) and b): Gait speed (average, average per sec-
tion, and maximum), number of steps, number and dur-
ation of stops, and greatest distance between stops will
be derived from the raw GPS/IMU data. Average gait
speed (distance/time) and number of steps will also be
derived from timing and video recording.
Task c): Gait speed (average, average per section, and
maximum), number of steps, number and duration of
stops, and greatest distance between stops will be de-
rived from the raw GPS/IMU data.
Task d): Previously suggested approaches to derive
summary measures of life-space from GPS data will be
used (including convex hull and standard deviation el-
lipse) [77].
Traditional physical function tests and physical activity
In addition to the GPS/IMU-based measurements, phys-
ical function will also be assessed by a battery of trad-
itional functional geriatric tests at T0 (before the GPS/
IMU measurements) at the study center: short physical
performance battery [24], single-leg stance [78], timed
“Up & Go” [26], and grip strength (Jamar plus dyna-
mometer, Sammons Preston, Bolingbrook, IL) [79]. Add-
itionally, habitual physical activity will be assessed by the
use of a wrist-worn activity tracker (vivofit 2, Garmin
Ltd., Olathe, KS, USA) the week after T0.
Further measures
The following participant characteristics will be assessed
within the baseline (T0) assessment (self-report): sex,
age, residential area (urban, suburban or rural), living
condition (alone or with someone else), socio-economic
status (financial hardship and years of education),
current walking ability (no walking aid, cane or rollator),
frequency of falls (12-month recall) [80], sports partici-
pation [81], gait efficacy (modified Gait Efficacy Scale)
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[82, 83], perceived health status and disability (WHO-
DAS 2.0 12-item version) [84], and chronic diseases (ac-
cording to the inclusion criteria, see above). Height and
weight will be measured by a trained assessor.
Participants will be given a diary for the one-week
measurement, where they will note how often they left
their homes, if they carried the GPS device and smart-
phone and if they have worn the activity tracker for at
least 10 h a day.
Measurements in study 2
Smartphone measurements
Study 2 will use smartphones fitted with the newly de-
veloped application. Patients will be instructed by a re-
search team member on how to use the application. The
application will be mostly self-explaining. Participants
will be asked to take along the smartphone fitted with
the application for a 1-week period. They should inde-
pendently perform one continuous GPS/IMU measure-
ment during a 30-min stroll in a park of their choice at
self-selected, usual pace (to determine gait speed). Fur-
thermore, participants’ position will be recorded by GPS
over this period to determine life-space.
Further measures
Sex, age, height and weight, residential area (urban, sub-
urban or rural; self-reported) and current walking ability
(self-reported) will be documented. After finishing the 1
week measurements, participants will be contacted by a
research member and they will be asked to rate the us-
ability of the tool.
Furthermore, aggregated results will be presented to
participating GPs. They will be asked to rate the usability
of the tool and the usefulness of the obtained
information.
Statistical analyses
Participant characteristics (demographics, history of falls,
chronic conditions etc.) will be analysed descriptively.
Study 1
Objectives 1 and 2 Test-retest reliability and validity
will be assessed by calculating Intraclass Correlation Co-
efficients (ICCs) [85]. Agreement will also be assessed by
performing Bland-Altman-Analyses [86]. In addition to
ICCs, recently developed information-based measures to
quantify reliability will be considered [87].
Objectives 3 and 4 Test-retest reliability will be assessed
by calculating ICCs [85] (as well as information-based
measures [87]). Again, Bland-Altman-Analyses will be
performed [86]. Concurrent validity will be assessed by
estimating correlations or associations (depending on the
level of measurement of the respective parameters).
Objective 5 The above mentioned estimation proce-
dures will be performed stratified by subgroups (based
on demographic characteristics, anthropometrics, and
physical function measures).
Objective 6 Measures of physical function and life-
space will be analysed (descriptive statistics and 95%
confidence intervals) for the total sample and stratified
by subgroups (based on demographic characteristics,
physical activity level, gait efficacy, and morbidity).
Objective 7 Inter-instrument agreement (as well as
agreement between wearing locations) will be assessed
by calculating ICCs [85] (as well as information-based
measures [87]) and by performing Bland-Altman-
Analyses [86].
Objective 8 Inter-rater agreement between levels of mo-
bility based on traditional measures and the new
smartphone-based measures will be assessed using
Cohen’s Kappa [88]. Optimal cut-offs for the new mea-
sures will be chosen such that Cohen’s Kappa is
maximized.
Study 2
Objective 9 The proportion (with 95% confidence inter-
val) of satisfactory recordings (according to predefined
criteria) [71] for the estimation of both life-space (con-
tinuous 1-week measurement) and physical function
(30-min stroll in the park) will be calculated and pre-
sented for the total sample as well as stratified by rele-
vant subgroups (defined based on findings of Study 1).
Reasons for unsatisfactory recordings will be analysed.
Furthermore, the obtained physical function and life-
space data will be analysed descriptively for the total
sample and stratified by relevant subgroups.
Objective 10 Acceptance by GPs and patients will be
analysed by descriptive statistics.
Objective 11 Logistic regression models will be used to
assess participant characteristics that are associated with
the proportion of satisfactory recordings.
Sample size calculation
Study 1
The primary analysis is the estimation of the ICC (95%
confidence interval) between the T0 and T1 value of the
GPS/IMU-derived average walking speed during the 30-
min stroll in the park. To estimate an ICC of 0.9 with an
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expected 95% confidence interval width of 0.1, 61 pa-
tients will be necessary (underlying assumption based on
results of Gernigon et al. [72]) [89]. Accounting for an
anticipated drop-out rate of 15%, the target sample size
is 72.
Study 2
The primary analysis is the estimation of the proportion
of satisfactory GPS recordings from the 30-min stroll in
the park. Assuming that 80% of GPS measurements will
be successful (based on results of Gernigon et al. [71]
(85%), but being more conservative due to the higher
age and morbidity of participants in our study), 60
patients are needed to achieve an expected width for a
95% confidence interval of 0.2. We will use the Wilson
interval which is an improvement over the traditional
Wald-type interval [90]. No drop-outs are assumed for
this study because there is no follow-up.
Discussion
MOBITEC-GP will provide the prerequisites for a novel
tool for primary health care, offering GPs the opportun-
ity to routinely assess their older adult patients’ mobility
and to recognize impending needs within pre-clinical
stages of decline.
Making use of technologies that are embedded in
smartphones offers a cost-effective opportunity as these
devices are already available and no “extra device” is
needed. The proportion of smartphone owners in the
population is growing rapidly: between 2013 and 2018 it
has increased from 70 to 90% in the general Swiss popu-
lation [91]. Even though an US survey (2015) has shown
that the proportion of smartphone users among those
aged 65+ (27%) is still markedly lower than in the youn-
ger age categories (54% in those aged 50 to 64) [92], it
can be expected that smartphone use in old age will in-
crease in the future – substantially but not exclusively
due to the aging of middle aged smartphone users [92].
A recent survey among patients after surgery showed
that even though older patients were less likely to have a
smartphone, they were just as interested and willing as
their younger counterparts to engage with mobile health
technologies [93].
Furthermore, the measurement as designed in
MOBITEC-GP do not need supervision and thus are not
personnel consuming. This will facilitate the use of these
measures in primary health care as well as in future
large-scale cohort studies, aiming to determine or con-
firm clinical cut-offs for targeted intervention. The ad-
vent of electronic medical records will provide an
opportunity to link in situ mobility monitoring with
medical records and to integrate algorithms that auto-
matically detect critical values for fall risk and social iso-
lation. The new tool could also provide an objective
measure for other health care professionals, such as so-
cial workers, occupational therapists or physiotherapists,
when life-changing decisions such as moving into a
nursing home have to be made; or alternatively, ambula-
tory services have to be planned in order to enable older
adults to stay in their own homes. Finally, the new tool
might facilitate further research on the relationship be-
tween older adults’ functioning and their (geographical
and social) environment.
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